COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10X GENOMICS INC | CL A COM | 88025U109 | 10,762 | 76,000 | SH | | SOLE | | 76,000 | 0 | 0 |
ABCAM PLC | ADS | 000380204 | 19,934 | 925,000 | SH | | SOLE | | 925,000 | 0 | 0 |
ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 35,182 | 700,000 | SH | | SOLE | | 700,000 | 0 | 0 |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 86,204 | 1,612,500 | SH | | SOLE | | 1,612,500 | 0 | 0 |
ACCOLADE INC | COM | 00437E102 | 21,750 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
ACELRX PHARMACEUTICALS INC | COM | 00444T100 | 4,690 | 3,782,457 | SH | | SOLE | | 3,782,457 | 0 | 0 |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 17,314 | 2,676,100 | SH | | SOLE | | 2,676,100 | 0 | 0 |
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 8,328 | 1,545,000 | SH | | SOLE | | 1,545,000 | 0 | 0 |
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 37,548 | 635,000 | SH | | SOLE | | 635,000 | 0 | 0 |
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 12,435 | 1,580,000 | SH | | SOLE | | 1,580,000 | 0 | 0 |
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 109,344 | 2,523,521 | SH | | SOLE | | 2,523,521 | 0 | 0 |
AKERO THERAPEUTICS INC | COM | 00973Y108 | 13,297 | 515,371 | SH | | SOLE | | 515,371 | 0 | 0 |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 47,927 | 306,750 | SH | | SOLE | | 306,750 | 0 | 0 |
ALIGN TECHNOLOGY INC | COM | 016255101 | 87,371 | 163,500 | SH | | SOLE | | 163,500 | 0 | 0 |
ALLAKOS INC | COM | 01671P100 | 47,810 | 341,500 | SH | | SOLE | | 341,500 | 0 | 0 |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 43,540 | 335,000 | SH | | SOLE | | 335,000 | 0 | 0 |
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 20,514 | 4,195,000 | SH | | SOLE | | 4,195,000 | 0 | 0 |
AMICUS THERAPEUTICS INC | COM | 03152W109 | 23,760 | 1,029,000 | SH | | SOLE | | 1,029,000 | 0 | 0 |
ANAPTYSBIO INC | COM | 032724106 | 6,652 | 309,413 | SH | | SOLE | | 309,413 | 0 | 0 |
ANNEXON INC | COM | 03589W102 | 1,137 | 45,413 | SH | | SOLE | | 45,413 | 0 | 0 |
APPLIED THERAPEUTICS INC | COM | 03828A101 | 13,995 | 635,837 | SH | | SOLE | | 635,837 | 0 | 0 |
ARDELYX INC | COM | 039697107 | 33,308 | 5,148,112 | SH | | SOLE | | 5,148,112 | 0 | 0 |
ARGENX SE | SPONSORED ADR | 04016X101 | 84,551 | 287,500 | SH | | SOLE | | 287,500 | 0 | 0 |
ARVINAS INC | COM | 04335A105 | 63,358 | 746,000 | SH | | SOLE | | 746,000 | 0 | 0 |
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 38,943 | 233,500 | SH | | SOLE | | 233,500 | 0 | 0 |
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 70,917 | 1,697,403 | SH | | SOLE | | 1,697,403 | 0 | 0 |
ATHIRA PHARMA INC | COM | 04746L104 | 29,486 | 860,902 | SH | | SOLE | | 860,902 | 0 | 0 |
ATRECA INC | CL A COM | 04965G109 | 7,287 | 451,230 | SH | | SOLE | | 451,230 | 0 | 0 |
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 10,700 | 773,669 | SH | | SOLE | | 773,669 | 0 | 0 |
BAXTER INTL INC | COM | 071813109 | 24,152 | 301,000 | SH | | SOLE | | 301,000 | 0 | 0 |
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 3,442 | 309,000 | SH | | SOLE | | 309,000 | 0 | 0 |
BEIGENE LTD | SPONSORED ADR | 07725L102 | 58,138 | 225,000 | SH | | SOLE | | 225,000 | 0 | 0 |
BIOGEN INC | COM | 09062X103 | 24,486 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
BIOGEN INC | COM | 09062X103 | 31,832 | 130,000 | SH | Call | SOLE | | 130,000 | 0 | 0 |
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 22,229 | 253,500 | SH | | SOLE | | 253,500 | 0 | 0 |
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 94,430 | 842,000 | SH | | SOLE | | 842,000 | 0 | 0 |
BOSTON SCIENTIFIC CORP | COM | 101137107 | 28,760 | 800,000 | SH | | SOLE | | 800,000 | 0 | 0 |
BRIGHT HORIZONS FAM SOL IN D | COM | 109194100 | 28,630 | 165,500 | SH | | SOLE | | 165,500 | 0 | 0 |
CENTENE CORP DEL | COM | 15135B101 | 43,822 | 730,000 | SH | | SOLE | | 730,000 | 0 | 0 |
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 16,563 | 999,000 | SH | | SOLE | | 999,000 | 0 | 0 |
CERTARA INC | COM | 15687V109 | 5,058 | 150,000 | SH | | SOLE | | 150,000 | 0 | 0 |
CHIASMA INC | COM | 16706W102 | 9,294 | 2,136,514 | SH | | SOLE | | 2,136,514 | 0 | 0 |
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 10,608 | 668,849 | SH | | SOLE | | 668,849 | 0 | 0 |
COHERUS BIOSCIENCES INC | COM | 19249H103 | 20,204 | 1,162,500 | SH | | SOLE | | 1,162,500 | 0 | 0 |
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 22,033 | 1,100,000 | SH | | SOLE | | 1,100,000 | 0 | 0 |
COMPUGEN LTD | ORD | M25722105 | 13,728 | 1,133,600 | SH | | SOLE | | 1,133,600 | 0 | 0 |
CONMED CORP | COM | 207410101 | 8,736 | 78,000 | SH | | SOLE | | 78,000 | 0 | 0 |
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 6,703 | 232,743 | SH | | SOLE | | 232,743 | 0 | 0 |
COVETRUS INC | COM | 22304C100 | 36,931 | 1,285,000 | SH | | SOLE | | 1,285,000 | 0 | 0 |
CYTOKINETICS INC | NOTE 4.000%11/1 | 23282WAA8 | 17,270 | 8,000,000 | PRN | | SOLE | | 8,000,000 | 0 | 0 |
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 7,340 | 1,649,420 | SH | | SOLE | | 1,649,420 | 0 | 0 |
EARGO INC | COM | 270087109 | 40,338 | 900,000 | SH | | SOLE | | 900,000 | 0 | 0 |
EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 53,096 | 582,000 | SH | | SOLE | | 582,000 | 0 | 0 |
ENCOMPASS HEALTH CORP | COM | 29261A100 | 41,345 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
EPIZYME INC | COM | 29428V104 | 27,728 | 2,553,208 | SH | | SOLE | | 2,553,208 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 2,196 | 206,000 | SH | | SOLE | | 206,000 | 0 | 0 |
EXACT SCIENCES CORP | COM | 30063P105 | 64,258 | 485,000 | SH | | SOLE | | 485,000 | 0 | 0 |
FIBROGEN INC | COM | 31572Q808 | 11,475 | 309,387 | SH | | SOLE | | 309,387 | 0 | 0 |
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 12,275 | 721,633 | SH | | SOLE | | 721,633 | 0 | 0 |
FRESHPET INC | COM | 358039105 | 71,918 | 506,500 | SH | | SOLE | | 506,500 | 0 | 0 |
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 11,143 | 948,327 | SH | | SOLE | | 948,327 | 0 | 0 |
GALAPAGOS NV | SPON ADR | 36315X101 | 16,332 | 165,000 | SH | | SOLE | | 165,000 | 0 | 0 |
GALERA THERAPEUTICS INC | COM | 36338D108 | 5,806 | 567,552 | SH | | SOLE | | 567,552 | 0 | 0 |
GAMIDA CELL LTD | SHS | M47364100 | 17,569 | 2,094,000 | SH | | SOLE | | 2,094,000 | 0 | 0 |
GLOBAL CORD BLOOD CORPORATIO | SHS | G39342103 | 2,875 | 775,000 | SH | | SOLE | | 775,000 | 0 | 0 |
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 14,184 | 15,573,000 | PRN | | SOLE | | 15,573,000 | 0 | 0 |
GUARDANT HEALTH INC | COM | 40131M109 | 25,776 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 13,755 | 119,188 | SH | | SOLE | | 119,188 | 0 | 0 |
HCA HEALTHCARE INC | COM | 40412C101 | 74,007 | 450,000 | SH | | SOLE | | 450,000 | 0 | 0 |
HEALTH CATALYST INC | COM | 42225T107 | 34,171 | 785,000 | SH | | SOLE | | 785,000 | 0 | 0 |
HEALTHEQUITY INC | COM | 42226A107 | 5,228 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 1,757 | 154,500 | SH | | SOLE | | 154,500 | 0 | 0 |
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 45,719 | 625,000 | SH | | SOLE | | 625,000 | 0 | 0 |
HUMANA INC | COM | 444859102 | 116,927 | 285,000 | SH | | SOLE | | 285,000 | 0 | 0 |
IDEXX LABS INC | COM | 45168D104 | 62,484 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
IMARA INC | COM | 45249V107 | 7,949 | 360,500 | SH | | SOLE | | 360,500 | 0 | 0 |
IMMUNOVANT INC | COM | 45258J102 | 41,155 | 891,000 | SH | | SOLE | | 891,000 | 0 | 0 |
INCYTE CORP | COM | 45337C102 | 26,094 | 300,000 | SH | | SOLE | | 300,000 | 0 | 0 |
INOZYME PHARMA INC | COM | 45790W108 | 17,142 | 830,546 | SH | | SOLE | | 830,546 | 0 | 0 |
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 6,763 | 6,000,000 | PRN | | SOLE | | 6,000,000 | 0 | 0 |
INSPIRE MED SYS INC | COM | 457730109 | 40,129 | 213,350 | SH | | SOLE | | 213,350 | 0 | 0 |
INSULET CORP | COM | 45784P101 | 81,290 | 318,000 | SH | | SOLE | | 318,000 | 0 | 0 |
INTERSECT ENT INC | COM | 46071F103 | 16,030 | 700,000 | SH | | SOLE | | 700,000 | 0 | 0 |
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 98,172 | 120,000 | SH | | SOLE | | 120,000 | 0 | 0 |
INVITAE CORP | COM | 46185L103 | 77,435 | 1,852,067 | SH | | SOLE | | 1,852,067 | 0 | 0 |
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 148,256 | 625,000 | SH | | SOLE | | 625,000 | 0 | 0 |
ITEOS THERAPEUTICS INC | COM | 46565G104 | 5,410 | 159,957 | SH | | SOLE | | 159,957 | 0 | 0 |
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 14,442 | 87,500 | SH | | SOLE | | 87,500 | 0 | 0 |
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,124 | 206,200 | SH | | SOLE | | 206,200 | 0 | 0 |
KARUNA THERAPEUTICS INC | COM | 48576A100 | 24,783 | 243,950 | SH | | SOLE | | 243,950 | 0 | 0 |
KINNATE BIOPHARMA INC | COM | 49705R105 | 12,916 | 324,686 | SH | | SOLE | | 324,686 | 0 | 0 |
KURA ONCOLOGY INC | COM | 50127T109 | 16,595 | 508,116 | SH | | SOLE | | 508,116 | 0 | 0 |
KYMERA THERAPEUTICS INC | COM | 501575104 | 44,260 | 713,865 | SH | | SOLE | | 713,865 | 0 | 0 |
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 8,713 | 309,418 | SH | | SOLE | | 309,418 | 0 | 0 |
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 2,200 | 206,200 | SH | | SOLE | | 206,200 | 0 | 0 |
MACROGENICS INC | COM | 556099109 | 7,075 | 309,510 | SH | | SOLE | | 309,510 | 0 | 0 |
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 28,545 | 256,768 | SH | | SOLE | | 256,768 | 0 | 0 |
MERSANA THERAPEUTICS INC | COM | 59045L106 | 54,914 | 2,063,667 | SH | | SOLE | | 2,063,667 | 0 | 0 |
MIRATI THERAPEUTICS INC | COM | 60468T105 | 81,959 | 373,152 | SH | | SOLE | | 373,152 | 0 | 0 |
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 26,129 | 1,496,525 | SH | | SOLE | | 1,496,525 | 0 | 0 |
MYOVANT SCIENCES LTD | COM | G637AM102 | 14,224 | 515,000 | SH | | SOLE | | 515,000 | 0 | 0 |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 150,964 | 1,575,000 | SH | | SOLE | | 1,575,000 | 0 | 0 |
NEUROCRINE BIOSCIENCES INC | NOTE 2.250% 5/1 | 64125CAD1 | 1,390 | 1,000,000 | PRN | | SOLE | | 1,000,000 | 0 | 0 |
NEVRO CORP | COM | 64157F103 | 68,375 | 395,000 | SH | | SOLE | | 395,000 | 0 | 0 |
NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 912 | 500,000 | PRN | | SOLE | | 500,000 | 0 | 0 |
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 10,921 | 360,500 | SH | | SOLE | | 360,500 | 0 | 0 |
NKARTA INC | COM | 65487U108 | 33,255 | 541,000 | SH | | SOLE | | 541,000 | 0 | 0 |
NOVAVAX INC | COM NEW | 670002401 | 62,803 | 563,205 | SH | | SOLE | | 563,205 | 0 | 0 |
NOVOCURE LTD | ORD SHS | G6674U108 | 30,282 | 175,000 | SH | | SOLE | | 175,000 | 0 | 0 |
NURIX THERAPEUTICS INC | COM | 67080M103 | 8,458 | 257,250 | SH | | SOLE | | 257,250 | 0 | 0 |
OAK STR HEALTH INC | COM | 67181A107 | 22,935 | 375,000 | SH | | SOLE | | 375,000 | 0 | 0 |
ODONATE THERAPEUTICS INC | COM | 676079106 | 7,252 | 377,700 | SH | | SOLE | | 377,700 | 0 | 0 |
ONESPAWORLD HOLDINGS LIMITED | COM | P73684113 | 6,997 | 690,000 | SH | | SOLE | | 690,000 | 0 | 0 |
PACIRA BIOSCIENCES INC | COM | 695127100 | 61,336 | 1,025,000 | SH | | SOLE | | 1,025,000 | 0 | 0 |
PACIRA BIOSCIENCES INC | NOTE 2.375% 4/0 | 695127AD2 | 1,149 | 1,000,000 | PRN | | SOLE | | 1,000,000 | 0 | 0 |
PANACEA ACQUISITION CORP | UNIT 99/99/9999 | 698102209 | 5,131 | 402,088 | SH | | SOLE | | 402,088 | 0 | 0 |
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 10,521 | 1,680,614 | SH | | SOLE | | 1,680,614 | 0 | 0 |
PENUMBRA INC | COM | 70975L107 | 27,825 | 159,000 | SH | | SOLE | | 159,000 | 0 | 0 |
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 4,416 | 1,314,374 | SH | | SOLE | | 1,314,374 | 0 | 0 |
PHREESIA INC | COM | 71944F106 | 46,121 | 850,000 | SH | | SOLE | | 850,000 | 0 | 0 |
POPULATION HEALTH INVS CO IN | UNIT 99/99/9999 | G71716123 | 2,101 | 201,044 | SH | | SOLE | | 201,044 | 0 | 0 |
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 3,179 | 289,754 | SH | | SOLE | | 289,754 | 0 | 0 |
PPD INC | COM | 69355F102 | 17,966 | 525,000 | SH | | SOLE | | 525,000 | 0 | 0 |
PRELUDE THERAPEUTICS INC | COM | 74065P101 | 25,784 | 360,363 | SH | | SOLE | | 360,363 | 0 | 0 |
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 15,572 | 643,200 | SH | | SOLE | | 643,200 | 0 | 0 |
PROTHENA CORP PLC | SHS | G72800108 | 13,705 | 1,141,100 | SH | | SOLE | | 1,141,100 | 0 | 0 |
PULMONX CORP | COM | 745848101 | 34,510 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 1,348 | 1,500,000 | PRN | | SOLE | | 1,500,000 | 0 | 0 |
RELAY THERAPEUTICS INC | COM | 75943R102 | 17,123 | 412,000 | SH | | SOLE | | 412,000 | 0 | 0 |
RETROPHIN INC | NOTE 2.500% 9/1 | 761299AB2 | 3,311 | 3,250,000 | PRN | | SOLE | | 3,250,000 | 0 | 0 |
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 14,578 | 490,339 | SH | | SOLE | | 490,339 | 0 | 0 |
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 16,600 | 4,742,891 | SH | | SOLE | | 4,742,891 | 0 | 0 |
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 21,956 | 400,370 | SH | | SOLE | | 400,370 | 0 | 0 |
ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | 24,024 | 480,000 | SH | | SOLE | | 480,000 | 0 | 0 |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 56,049 | 328,750 | SH | | SOLE | | 328,750 | 0 | 0 |
SEAGEN INC | COM | 81181C104 | 43,785 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
SHATTUCK LABS INC | COM | 82024L103 | 25,628 | 489,000 | SH | | SOLE | | 489,000 | 0 | 0 |
SHOCKWAVE MED INC | COM | 82489T104 | 22,818 | 220,000 | SH | | SOLE | | 220,000 | 0 | 0 |
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 9,095 | 567,358 | SH | | SOLE | | 567,358 | 0 | 0 |
SPERO THERAPEUTICS INC | COM | 84833T103 | 23,947 | 1,235,000 | SH | | SOLE | | 1,235,000 | 0 | 0 |
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 39,650 | 1,631,000 | SH | | SOLE | | 1,631,000 | 0 | 0 |
TELEFLEX INCORPORATED | COM | 879369106 | 53,504 | 130,000 | SH | | SOLE | | 130,000 | 0 | 0 |
TG THERAPEUTICS INC | COM | 88322Q108 | 25,438 | 489,000 | SH | | SOLE | | 489,000 | 0 | 0 |
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 12,052 | 678,200 | SH | | SOLE | | 678,200 | 0 | 0 |
THERAVANCE BIOPHARMA INC | NOTE 3.250%11/0 | 88339KAA0 | 1,420 | 1,500,000 | PRN | | SOLE | | 1,500,000 | 0 | 0 |
TRANSLATE BIO INC | COM | 89374L104 | 11,860 | 643,500 | SH | | SOLE | | 643,500 | 0 | 0 |
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 27,827 | 1,021,000 | SH | | SOLE | | 1,021,000 | 0 | 0 |
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 9,098 | 618,500 | SH | | SOLE | | 618,500 | 0 | 0 |
TURMERIC ACQUISITION CORP | UNIT 10/08/2025 | G9127T116 | 2,116 | 206,000 | SH | | SOLE | | 206,000 | 0 | 0 |
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 78,421 | 566,500 | SH | | SOLE | | 566,500 | 0 | 0 |
UNIQURE NV | SHS | N90064101 | 7,533 | 208,500 | SH | | SOLE | | 208,500 | 0 | 0 |
UNITEDHEALTH GROUP INC | COM | 91324P102 | 142,025 | 405,000 | SH | | SOLE | | 405,000 | 0 | 0 |
WEST PHARMACEUTICAL SVSC INC | COM | 955306105 | 8,074 | 28,500 | SH | | SOLE | | 28,500 | 0 | 0 |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 7,921 | 515,000 | SH | | SOLE | | 515,000 | 0 | 0 |
ZAI LAB LTD | ADR | 98887Q104 | 115,702 | 854,899 | SH | | SOLE | | 854,899 | 0 | 0 |